
|Slideshows|June 21, 2019
FDA approvals you might have missed
Author(s)Miranda Hester
A look at 5 recent approvals from the US Food and Drug Administration (FDA), including treatment for systemic lupus erythematosus, a new gene therapy, and pain relief for patients with irritable bowel syndrome.
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves gepotidacin as oral treatment for urogenital gonorrhea
2
Reports: FDA launching safety review of nirsevimab and clesrovimab for RSV
3
FDA approves powder formulation of trofinetide for Rett syndrome
4
FDA approves Waskyra as first gene therapy for Wiskott-Aldrich syndrome
5








